The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. © 2020 Market data provided is at least 10-minutes delayed and hosted by Sign-up to receive the latest news and ratings for ABMD and its competitors with MarketBeat's FREE daily newsletter.ABIOMED's stock was trading at $151.13 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. © 2020 Market data provided is at least 10-minutes delayed and hosted by
The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. Proceed with caution if you are considering to buy.Stock Target Advisor runs millions of automatic calculations on over 75,000 stocks in American, Asian and European Exchanges and compares it with market analyst stock ratings and target stock prices to help you make smart investment decisions and build robust investment portfolios.
Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Since then, ABMD stock has increased by 97.0% and is now trading at $297.73. Learn everything you need to know about successful options trading with this three-part video course.Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:You have already added five stocks to your watchlist. View ABMD's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. The average price target is $0.00 with a high estimate of $0.00 and a low estimate of $0.00. Please log in to your account or sign up in order to add this asset to your watchlist. 35 Wall Street analysts have issued ratings and price targets for Advanced Micro Devices in the last 12 months. Export data to Excel for your own analysis. All rights reserved. View which stocks are hot on social media with MarketBeat's trending stocks report.Identify stocks that meet your criteria using seven unique stock screeners. Interested parties can register for or listen to the call using ABIOMED, Inc. (NASDAQ:ABMD) released its quarterly earnings data on Thursday, April, 30th. The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile. As of June 30th, there was short interest totaling 2,360,000 shares, a decline of 13.6% from the June 15th total of 2,730,000 shares. The stock is trading high compared to its peers on a price to cash flow basis. The medical equipment provider earned $206.66 million during the quarter, compared to the consensus estimate of $209.58 million. ABIOMED employs 1,536 workers across the globe.The official website for ABIOMED is ABIOMED's mailing address is 22 CHERRY HILL DR, DANVERS MA, 01923. Mean consensus: OUTPERFORM: Number of Analysts: 10: Average target price: 223,33 $ Last Close Price: 263,84 $ Spread / Highest target View real-time stock prices and stock quotes for a full financial overview.
Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. ABMD | Complete Abiomed Inc. stock news by MarketWatch.
ABIOMED is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. ABIOMED had a net margin of 24.14% and a return on equity of 18.51%. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. Learn everything you need to know about successful options trading with this three-part video course.Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:You have already added five stocks to your watchlist.
This suggests that the stock has a possible downside of 35.2%. The price of ABMD has continued on a strong uptrend for over 3 months now. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks.
Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The high price target for ABMD is $240.00 and the low price target for ABMD is $152.00. The stock is trading high compared to its peers median on a price to book value basis. Mean consensus: OUTPERFORM: Number of Analysts: 10: Average target price: 223,33 $ Last Close Price: 263,84 $ Spread / Highest target During the same quarter in the previous year, the firm posted $1.60 EPS.